ERR2208971
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- ALLOGRAFT_REJECTION+0.300
- INTERFERON_ALPHA_RESPONSE+0.300
- INTERFERON_GAMMA_RESPONSE+0.300
- IL6_JAK_STAT3_SIGNALING+0.100
- TNFA_SIGNALING_VIA_NFKB+0.100
- UV_RESPONSE_DN+0.100
- WNT_BETA_CATENIN_SIGNALING+0.100
- APICAL_JUNCTION+0.000
- HEDGEHOG_SIGNALING+0.000
- INFLAMMATORY_RESPONSE+0.000
Top 10 suppressed
- MYC_TARGETS_V1-0.700
- OXIDATIVE_PHOSPHORYLATION-0.600
- E2F_TARGETS-0.500
- MTORC1_SIGNALING-0.500
- PROTEIN_SECRETION-0.500
- ADIPOGENESIS-0.400
- ANDROGEN_RESPONSE-0.400
- MYC_TARGETS_V2-0.400
- REACTIVE_OXYGEN_SPECIES_PATHWAY-0.400
- ANGIOGENESIS-0.300
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | X65f5effa.07f7.4ed3.9e0a.3a0d9d451474 | — | cohortA1 | 0.902 |
| 2 | s0122234 | — | — | 0.880 |
| 3 | ERR2208899 | — | — | 0.868 |
| 4 | TCGA-MN-A4N5-01A-11R-A24X-07 | — | cohortA1 | 0.864 |
| 5 | AUR-AFSP-TTP1-A-8-0-R-A741-41 | — | D | 0.855 |
| 6 | SRR5088847 | — | — | 0.853 |
| 7 | 20040121.LumB | — | D | 0.849 |
| 8 | 7b837bdd-5a59-47f6-a1aa-259142234bd5 | — | — | 0.844 |
| 9 | TCGA-AC-A3OD-01B-06R-A22O-07 | — | D | 0.844 |
| 10 | bae6fdb5-9df3-433c-9a4c-e5c159a62bc6 | — | — | 0.839 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 7 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| ALLOGRAFT_REJECTION | 0.300 | Idelalisib | — uncovered |
| INTERFERON_ALPHA_RESPONSE | 0.300 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.300 | Idelalisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.100 | Inavolisib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.100 | Inavolisib | — uncovered |
| UV_RESPONSE_DN | 0.100 | Inavolisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.100 | Inavolisib | — uncovered |